Published in Urol Oncol on July 13, 2007
Do anti-angiogenic VEGF (VEGFxxxb) isoforms exist? A cautionary tale. PLoS One (2012) 1.02
Expression of livin and vascular endothelial growth factor in different clinical stages of human esophageal carcinoma. World J Gastroenterol (2008) 0.84
Expression and clinical significance of hepaCAM and VEGF in urothelial carcinoma. World J Urol (2010) 0.83
Sensing movement: microsensors for body motion measurement. Sensors (Basel) (2011) 3.27
VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res (2002) 3.19
NONCODE: an integrated knowledge database of non-coding RNAs. Nucleic Acids Res (2005) 3.16
VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res (2004) 3.03
Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease. Ann Neurol (2008) 2.95
Topological structure analysis of the protein-protein interaction network in budding yeast. Nucleic Acids Res (2003) 2.90
Identification of a novel risk variant in the FUS gene in essential tremor. Neurology (2013) 2.84
NONCODE v3.0: integrative annotation of long noncoding RNAs. Nucleic Acids Res (2011) 2.82
An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell (2011) 2.78
Large-scale prediction of long non-coding RNA functions in a coding-non-coding gene co-expression network. Nucleic Acids Res (2011) 2.55
NONCODEv4: exploring the world of long non-coding RNA genes. Nucleic Acids Res (2013) 2.37
A new postoperative predictor of time to urinary continence after laparoscopic radical prostatectomy: the urine loss ratio. Eur Urol (2006) 2.22
Large-scale replication and heterogeneity in Parkinson disease genetic loci. Neurology (2012) 2.18
Prognostic factors and predictive models in renal cell carcinoma: a contemporary review. Eur Urol (2011) 2.10
PlantTFDB 2.0: update and improvement of the comprehensive plant transcription factor database. Nucleic Acids Res (2010) 2.09
Digital pathology: exploring its applications in diagnostic surgical pathology practice. Pathology (2010) 2.05
IMP-4 and OXA beta-lactamases in Acinetobacter baumannii from Singapore. J Antimicrob Chemother (2007) 1.98
Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma. J Hepatol (2008) 1.87
Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade. J Clin Invest (2009) 1.80
Organization of the Caenorhabditis elegans small non-coding transcriptome: genomic features, biogenesis, and expression. Genome Res (2005) 1.77
NONCODE v2.0: decoding the non-coding. Nucleic Acids Res (2007) 1.69
Identification of circulating microRNA signatures for breast cancer detection. Clin Cancer Res (2013) 1.67
US-guided percutaneous microwave coagulation of small breast cancers: a clinical study. Radiology (2012) 1.66
Utilizing sequence intrinsic composition to classify protein-coding and long non-coding transcripts. Nucleic Acids Res (2013) 1.64
Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J Urol (2013) 1.64
SLC1A2 variant associated with essential tremor but not Parkinson disease in Chinese subjects. Neurology (2013) 1.61
A molecular classification of papillary renal cell carcinoma. Cancer Res (2005) 1.60
Glucocerebrosidase mutations and risk of Parkinson disease in Chinese patients. Arch Neurol (2007) 1.58
Genomic structure of human OKL38 gene and its differential expression in kidney carcinogenesis. J Biol Chem (2003) 1.58
Long-term follow-up of the treatment of renal angiomyolipomas after selective arterial embolization with alcohol. BJU Int (2009) 1.58
Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study. Hum Mutat (2010) 1.57
Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis. BMC Gastroenterol (2003) 1.55
Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J (2005) 1.54
Comparison of the UCLA Integrated Staging System and the Leibovich score in survival prediction for patients with nonmetastatic clear cell renal cell carcinoma. Urology (2010) 1.52
Triggering of toll-like receptor-4 in human multiple myeloma cells promotes proliferation and alters cell responses to immune and chemotherapy drug attack. Cancer Biol Ther (2011) 1.50
Wild-type and 'a' epitope variants in chronic hepatitis B virus carriers positive for hepatitis B surface antigen and antibody. J Gastroenterol Hepatol (2002) 1.50
Methylene blue protects against paraquat-induced acute lung injury in rats. Int Immunopharmacol (2013) 1.47
Long non-coding RNAs function annotation: a global prediction method based on bi-colored networks. Nucleic Acids Res (2012) 1.46
ncFANs: a web server for functional annotation of long non-coding RNAs. Nucleic Acids Res (2011) 1.46
Shockwaves increase T-cell proliferation and IL-2 expression through ATP release, P2X7 receptors, and FAK activation. Am J Physiol Cell Physiol (2009) 1.46
Road Traffic Injury Prevention Initiatives: A Systematic Review and Metasummary of Effectiveness in Low and Middle Income Countries. PLoS One (2016) 1.46
Influence of E3 region on conditionally replicative adenovirus mediated cytotoxicity in hepatocellular carcinoma cells. Cancer Biol Ther (2009) 1.45
Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations. Clin Cancer Res (2004) 1.44
Adenomatous polyposis coli (APC)-independent regulation of beta-catenin degradation via a retinoid X receptor-mediated pathway. J Biol Chem (2003) 1.43
ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol (2012) 1.43
Diagnostic issues in second opinion consultations in prostate pathology. Pathology (2010) 1.42
Ureteral reimplantation for management of ureteral strictures: a retrospective comparison of laparoscopic and open techniques. Eur Urol (2006) 1.41
Remission of rheumatoid arthritis and potential determinants: a national multi-center cross-sectional survey. Clin Rheumatol (2014) 1.41
Intratumor injection of oncolytic adenovirus expressing HSP70 prolonged survival in melanoma B16 bearing mice by enhanced immune response. Cancer Biol Ther (2007) 1.40
Clinically reported heterozygous mutations in the PINK1 kinase domain exert a gene dosage effect. Hum Mutat (2009) 1.39
A rare case of localised AA-type amyloidosis of the ureter with spheroids of amyloid. Singapore Med J (2012) 1.39
Gene expression profile of murine long-term reconstituting vs. short-term reconstituting hematopoietic stem cells. Proc Natl Acad Sci U S A (2005) 1.32
Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer. Mod Pathol (2009) 1.32
Hormone receptor and c-ERBB2 status in distant metastatic and locally recurrent breast cancer. Pathologic correlations and clinical significance. Am J Clin Pathol (2010) 1.29
Clustered microRNAs' coordination in regulating protein-protein interaction network. BMC Syst Biol (2009) 1.28
Do primary mammary osteosarcoma and chondrosarcoma exist? A review of a large multi-institutional series of malignant matrix-producing breast tumours. Breast (2012) 1.27
Prostate Cancer Working Group report. Jpn J Clin Oncol (2010) 1.25
Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers. Am J Surg Pathol (2010) 1.25
NPInter: the noncoding RNAs and protein related biomacromolecules interaction database. Nucleic Acids Res (2006) 1.24
Development of a next-generation sequencing method for BRCA mutation screening: a comparison between a high-throughput and a benchtop platform. J Mol Diagn (2012) 1.21
Murine hematopoietic stem cell distribution and proliferation in ablated and nonablated bone marrow transplantation. Blood (2002) 1.21
dbDEMC: a database of differentially expressed miRNAs in human cancers. BMC Genomics (2010) 1.20
Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis. Anal Chim Acta (2012) 1.20
PPAR-gamma: therapeutic target for ischemic stroke. Trends Pharmacol Sci (2007) 1.20
The bright side of JNKs-Multitalented mediators in neuronal sprouting, brain development and nerve fiber regeneration. Prog Neurobiol (2006) 1.20
Solid pseudopapillary tumour of the pancreas. ANZ J Surg (2003) 1.19
Validity of two self-report measures of sitting time. J Phys Act Health (2011) 1.18
Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death. Hum Mutat (2011) 1.16
Regulation of Nur77 expression by β-catenin and its mitogenic effect in colon cancer cells. FASEB J (2010) 1.14
LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort. J Proteome Res (2012) 1.14
NPInter v2.0: an updated database of ncRNA interactions. Nucleic Acids Res (2013) 1.13
Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing. Rheumatology (Oxford) (2011) 1.12
One-step microfluidic generation of pre-hatching embryo-like core-shell microcapsules for miniaturized 3D culture of pluripotent stem cells. Lab Chip (2013) 1.11
Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients. Am J Surg Pathol (2014) 1.11
The pathology of dengue hemorrhagic fever. Semin Diagn Pathol (2007) 1.10
Systems genetics of susceptibility to obesity-induced diabetes in mice. Physiol Genomics (2011) 1.10
Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma. BMC Cancer (2010) 1.08
LC-MS profiling of N-Glycans derived from human serum samples for biomarker discovery in hepatocellular carcinoma. J Proteome Res (2014) 1.08
Detection and comparison of epidermal growth factor receptor mutations in cells and fluid of malignant pleural effusion in non-small cell lung cancer. Lung Cancer (2007) 1.08
Prevalence and significance of anti-peptidylarginine deiminase 4 antibodies in rheumatoid arthritis. J Rheumatol (2008) 1.07
Recurrent phyllodes tumours of the breast: pathological features and clinical implications. ANZ J Surg (2006) 1.06
Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer. Breast Cancer Res Treat (2012) 1.06
Cyclic compressive loading facilitates recovery after eccentric exercise. Med Sci Sports Exerc (2008) 1.05
Bonding the foe - NETting neutrophils immobilize the pro-inflammatory monosodium urate crystals. Front Immunol (2012) 1.04
Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors. Breast (2010) 1.04
IL-12 facilitates both the recovery of endogenous hematopoiesis and the engraftment of stem cells after ionizing radiation. Exp Hematol (2007) 1.04
Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke. J Hypertens (2007) 1.03
Spindle cell lesions of the breast--the pathologic differential diagnosis. Breast Cancer Res Treat (2007) 1.03
FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers. Am J Transplant (2005) 1.03
Sustained blockade of brain AT1 receptors before and after focal cerebral ischemia alleviates neurologic deficits and reduces neuronal injury, apoptosis, and inflammatory responses in the rat. J Cereb Blood Flow Metab (2004) 1.02
RNA interference suppressing PLCE1 gene expression decreases invasive power of human bladder cancer T24 cell line. Cancer Genet Cytogenet (2010) 1.01
A molecular signature of the Nottingham prognostic index in breast cancer. Cancer Res (2004) 1.01
The gamma catenin/CBP complex maintains survivin transcription in β-catenin deficient/depleted cancer cells. Curr Cancer Drug Targets (2011) 1.01
c-erbB-2 (HER-2/neu) immunohistochemistry in invasive breast cancer: is there concordance between standard sections and tissue microarrays? Pathology (2006) 1.01
MicroRNA-encoding long non-coding RNAs. BMC Genomics (2008) 1.01
The interactome as a tree--an attempt to visualize the protein-protein interaction network in yeast. Nucleic Acids Res (2004) 1.00
Alu-directed transcriptional regulation of some novel miRNAs. BMC Genomics (2009) 1.00
Identifying Hfq-binding small RNA targets in Escherichia coli. Biochem Biophys Res Commun (2006) 1.00
Alpha synuclein promoter and risk of Parkinson's disease: microsatellite and allelic size variability. Neurosci Lett (2003) 1.00